NXS 4.76% 25.0¢ next science limited

Ann: Appendix 4C & Quarterly Activity Report - 31 December 2023, page-10

  1. 221 Posts.
    lightbulb Created with Sketch. 121
    When you are growing at 80% compound per annum and adding new customers daily, to expect your quarterly cashflow from sales to equal your quarterly revenue is just silly. I doubt they have many customers who are on a cash only basis. Most of their customers would have negotiated at least 30 days and probably more to pay their accounts. A fair few of their customers are huge hospital groups or medical conglomerates. As a consequence, there will always be a lag between a sale and receipt of cash and in a business growing like the clappers, this is even more pronounced.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
25.0¢
Change
-0.013(4.76%)
Mkt cap ! $72.92M
Open High Low Value Volume
26.5¢ 27.0¢ 25.0¢ $18.39K 70.75K

Buyers (Bids)

No. Vol. Price($)
1 20530 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 45500 2
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
26.0¢
  Change
-0.013 ( 0.00 %)
Open High Low Volume
27.0¢ 27.0¢ 26.0¢ 21249
Last updated 15.08pm 14/06/2024 ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.